Streptococcus pyogenes ranks among the main causes of mortality from bacterial infections worldwide. Currently there is no vaccine to prevent diseases such as rheumatic heart disease and invasive streptococcal infection. The streptococcal M protein that is used as the substrate for epidemiological typing is both a virulence factor and a vaccine antigen. Over 220 variants of this protein have been described, making comparisons between proteins difficult, and hindering M protein-based vaccine development. A functional classification based on 48 emm-clusters containing closely related M proteins that share binding and structural properties is proposed. The need for a paradigm shift from type-specific immunity against S. pyogenes to emm-cluster...
The prevalence of rheumatic heart disease (RHD) in the Aboriginal population of the Australian North...
Group A streptococci are model extracellular gram-positive pathogens responsible for pharyngitis, im...
A major challenge for Streptococcus pyogenes vaccine development is the identification of epitopes t...
International audienceStreptococcus pyogenes ranks among the main causes of mortality from bacterial...
Streptococcus pyogenes ranks amongst the main causes of mortality from bacterial infections worldwid...
Group A Streptococcus (GAS) M protein is an important virulence factor and potential vaccine antigen...
AbstractGroup A Streptococcus (GAS) M protein is an important virulence factor and potential vaccine...
The Gram-positive bacterium Streptococcus pyogenes, known as group A Streptococcus (GAS), is a wides...
Streptococcus pyogenes causes a wide variety of human diseases and is a significant cause of morbidi...
emm-cluster typing system allows to classify most Streptococcus pyogenes variants into 48 different ...
Diseases associated with Streptococcus pyogenes (Group A streptococcus, GAS) account for half a mill...
Streptococcus pyogenes causes a wide variety of human diseases and is a significant cause of morbidi...
TO THE EDITOR—A new emm-cluster typ-ing system has been recently proposed for group A Streptococcus ...
The prevalence of rheumatic heart disease (RHD) in the Aboriginal population of the Australian North...
emm-cluster typing system allows to classify most Streptococcus pyogenes variants into 48 different ...
The prevalence of rheumatic heart disease (RHD) in the Aboriginal population of the Australian North...
Group A streptococci are model extracellular gram-positive pathogens responsible for pharyngitis, im...
A major challenge for Streptococcus pyogenes vaccine development is the identification of epitopes t...
International audienceStreptococcus pyogenes ranks among the main causes of mortality from bacterial...
Streptococcus pyogenes ranks amongst the main causes of mortality from bacterial infections worldwid...
Group A Streptococcus (GAS) M protein is an important virulence factor and potential vaccine antigen...
AbstractGroup A Streptococcus (GAS) M protein is an important virulence factor and potential vaccine...
The Gram-positive bacterium Streptococcus pyogenes, known as group A Streptococcus (GAS), is a wides...
Streptococcus pyogenes causes a wide variety of human diseases and is a significant cause of morbidi...
emm-cluster typing system allows to classify most Streptococcus pyogenes variants into 48 different ...
Diseases associated with Streptococcus pyogenes (Group A streptococcus, GAS) account for half a mill...
Streptococcus pyogenes causes a wide variety of human diseases and is a significant cause of morbidi...
TO THE EDITOR—A new emm-cluster typ-ing system has been recently proposed for group A Streptococcus ...
The prevalence of rheumatic heart disease (RHD) in the Aboriginal population of the Australian North...
emm-cluster typing system allows to classify most Streptococcus pyogenes variants into 48 different ...
The prevalence of rheumatic heart disease (RHD) in the Aboriginal population of the Australian North...
Group A streptococci are model extracellular gram-positive pathogens responsible for pharyngitis, im...
A major challenge for Streptococcus pyogenes vaccine development is the identification of epitopes t...